Efficacy and Safety of Neosil on Chronic Effluvium (NCT03659201) | Clinical Trial Compass
CompletedPhase 4
Efficacy and Safety of Neosil on Chronic Effluvium
Brazil232 participantsStarted 2018-09-03
Plain-language summary
The purpose of this study is to evaluate the efficacy of Neosil in the treatment of chronic effluvium
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants who present hair loss for more than 6 months;
* Do not use other possible cosmetic or dermatological treatments, during the trial;
* Not change the diet during the trial and not be any restrictive diet during this period.
Exclusion Criteria:
* Pregnancy or risk of pregnancy and lactating patients;
* Use of any products to promote hair growth within the 6 months prior to the Baseline Visit;
* History of hair transplants;
* Current skin disease;
* History hypersensitivity to the active ingredients used in the study;
* Participation in clinical trial in the year prior to this study;
* Known history of non controled systemic disease (diabetes, hypertension, anemia, iron deficiency, and others);
* Gastric diseases;
* Smoker;
* History of systemic disease (HIV, non specify autoimmune disease, hepatitis, and others).